Literature DB >> 20651091

Sphingosine-1-phosphate signaling in human submandibular cells.

J Seo1, N Y Koo, W Y Choi, J A Kang, J H Min, S H Jo, S J Lee, S B Oh, J S Kim, J H Lee, S Y Choi, K Park.   

Abstract

Sphingosine-1-phosphate (S1P) is a significant lipid messenger modulating many physiological responses. S1P plays a critical role in autoimmune disease and is suggested to be involved in Sjögren's syndrome pathology. However, the mechanism of S1P signaling in salivary glands is unclear. Here we studied the effects of S1P on normal human submandibular gland cells. S1P increased levels of the intracellular Ca(2+) concentration ([Ca(2+)](i)), which was inhibited by pre-treatment with U73122 or 2-aminoethoxydiphenyl borate (2-APB). Pre-treated S1P did not inhibit subsequent carbachol-induced [Ca(2+)](i) increase, which suggests that S1P and muscarinic signaling are independent of each other. S1P1, S1P2, and S1P3 receptors SphK1 and SphK2 were commonly expressed in human salivary gland cells. S1P, but not carbachol, induces the expression of interleukin-6 and Fas. Our results suggest that S1P triggers Ca(2+) signaling and the apoptotic pathway in normal submandibular gland cells, which suggests in turn that S1P affects the progression of Sjögren's syndrome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20651091     DOI: 10.1177/0022034510376044

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  2 in total

1.  Epigenetic modulation of the muscarinic type 3 receptor in salivary epithelial cells.

Authors:  Yong-Hwan Shin; Meihong Jin; Sung-Min Hwang; Seul-Ki Choi; Eun Namkoong; Minkyoung Kim; Moon-Yong Park; Se-Young Choi; Jong-Ho Lee; Kyungpyo Park
Journal:  Lab Invest       Date:  2014-12-08       Impact factor: 5.662

2.  Role of LPA and the Hippo pathway on apoptosis in salivary gland epithelial cells.

Authors:  Sung-Min Hwang; MeiHong Jin; Yong Hwan Shin; Seul Ki Choi; Eun Namkoong; MinKyoung Kim; Moon-Yong Park; Kyungpyo Park
Journal:  Exp Mol Med       Date:  2014-12-12       Impact factor: 8.718

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.